BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 33597312)

  • 1. A benign cause of hyperandrogenism in a postmenopausal woman.
    Roque JJN; Alves IBS; Rodrigues AMAPF; Bugalho MJ
    Endocrinol Diabetes Metab Case Rep; 2021 Feb; 2021():. PubMed ID: 33597312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bilateral Leydig Cell Hyperplasia: A Rare Cause of Postmenopausal Hirsutism.
    Pathmanathan S; De Silva SDN; Sumanatilleke M; Lokuhetty D; Ranathunga UVV
    Case Rep Endocrinol; 2022; 2022():8804856. PubMed ID: 35190778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An ovarian Leydig cell tumor of ultrasound negative in a postmenopausal woman with hirsutism and hyperandrogenism: A case report.
    Chen M; Zhou W; Zhang Z; Zou Y; Li C
    Medicine (Baltimore); 2018 Mar; 97(10):e0093. PubMed ID: 29517680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Approach to Investigation of Hyperandrogenism in a Postmenopausal Woman.
    Hirschberg AL
    J Clin Endocrinol Metab; 2023 Apr; 108(5):1243-1253. PubMed ID: 36409990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A rare case of pure testosterone-secreting adrenal adenoma in a postmenopausal elderly woman.
    Zhou WB; Chen N; Li CJ
    BMC Endocr Disord; 2019 Jan; 19(1):14. PubMed ID: 30674304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Sertoli-Leydig cell tumour (arrhenoblastoma) in a patient with polycystic ovary syndrome: clinical, ultrasonographic, hormonal and histopathological evaluation].
    Puzigaća S; Prelević G; Svetenović Z; Djuricić S; Kokan Dj; Radivojević U
    Srp Arh Celok Lek; 2001; 129 Suppl 1():51-5. PubMed ID: 15637992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Total testosterone and DHEAS levels as predictors of androgen-secreting neoplasms: a populational study.
    Waggoner W; Boots LR; Azziz R
    Gynecol Endocrinol; 1999 Dec; 13(6):394-400. PubMed ID: 10685333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postmenopausal hyperandrogenism due to an ovarian sex cord-stromal tumour causing elevated dehydroepiandrosterone sulphate: a case report.
    Sumanatilleke M; de Silva NL; Ranaweera G; Appuhamy C; Karunaratne K; de Silva MVC
    BMC Womens Health; 2022 Jul; 22(1):297. PubMed ID: 35843927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.
    Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
    Endocr Pract; 2015 Nov; 21(11):1291-300. PubMed ID: 26509855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The case of the elusive androgen.
    Cobin RH
    Endocr Pract; 2002; 8(6):433-8. PubMed ID: 15260009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postmenopausal hyperandrogenism.
    Yoldemir T
    Climacteric; 2022 Apr; 25(2):109-117. PubMed ID: 33988479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperandrogenism in a postmenopausal woman: a rare case of ectopic adrenal cortical gland.
    Guarino A; Di Benedetto L; Giovanale V; Rampioni Vinciguerra GL; Stoppacciaro A; Bellati F; Caserta D
    Gynecol Endocrinol; 2017 Mar; 33(3):185-187. PubMed ID: 28102088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utilisation of gonadotrophin-releasing hormone (GnRH) analogue to differentiate ovarian from adrenal hyperandrogenism in postmenopausal women.
    Bahaeldein E; Brassill MJ
    Endocrinol Diabetes Metab Case Rep; 2018; 2018():. PubMed ID: 30481153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Marked hyperandrogenicity in a 60-year-old woman.
    Aljenaee K; Ali S; Cheah SK; MacEneaney O; Mulligan N; Hickey N; Tun TK; Sreenan S; McDermott JH
    Endocrinol Diabetes Metab Case Rep; 2017; 2017():. PubMed ID: 28924479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low leptin level in an obese hyperandrogenic woman--potential marker for androgen-secreting tumor.
    Cvijovic G; Yamashita SA; Micic D; Kendereski A; Sumarac-Dumanovic M; Zoric S; Popovic V
    Gynecol Endocrinol; 2007 Feb; 23(2):112-6. PubMed ID: 17454162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of cetrorelix in the investigation of testosterone excess in a postmenopausal woman.
    Chantler DJ; Gordon D; Millan D; Panarelli M
    BMJ Case Rep; 2011 Apr; 2011():. PubMed ID: 22696667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Case of Ovarian Hyperthecosis in a Postmenopausal Woman.
    Yousaf S; Nizar R; John L; Simpson A
    JCEM Case Rep; 2023 Nov; 1(6):luad148. PubMed ID: 38077307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ovarian Leydig cell tumor and postmenopausal hirsutism with signs of virilisation.
    Ferrinho C; Silva E; Oliveira M; Sequeira Duarte J
    BMJ Case Rep; 2021 Mar; 14(3):. PubMed ID: 33731391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of postmenopausal virilization.
    Alpañés M; González-Casbas JM; Sánchez J; Pián H; Escobar-Morreale HF
    J Clin Endocrinol Metab; 2012 Aug; 97(8):2584-8. PubMed ID: 22669303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bilateral Ovarian Leydig Cell Tumors in a Postmenopausal Woman Causing Hirsutism and Virilization.
    Shakir MKM; Snitchler AN; Vietor NO; Mai VQ; Hoang TD
    AACE Clin Case Rep; 2021; 7(1):26-28. PubMed ID: 33851015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.